Regulation of Protein Kinase C Theta by Phosphorylation
Regulation of Protein Kinase C Theta by Phosphorylation
批准号:
10679152
负责人:
Stefanie Jill Hodapp
金额:
$4.01万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-01 至 2026-03-31
关键词:
AffectAgonistAutoimmune DiseasesAutomobile DrivingBiochemicalBioinformaticsBiologicalBiological AssayBiological Response ModifiersBiologyBiosensorBlood PlateletsCD28 geneCellsCellular AssayClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsDiglyceridesDiseaseEnzymesExhibitsExperimental DesignsGenesGoalsHematological DiseaseHematopoieticHematopoietic NeoplasmsHemostatic functionHydrolysisHydrophobicityImmune System DiseasesImmune signalingIn VitroInflammatoryInvestigationIsoenzymesJurkat CellsKnowledgeLaboratoriesLocationLuciferasesMass Spectrum AnalysisMolecularMutationPathologyPathway interactionsPhospholipidsPhosphorylationPhosphotransferasesPlatelet ActivationPlayPositioning AttributePropertyProtein Kinase CRegulationReporterResearchRoleSignal PathwaySignal TransductionSiteT-Cell ReceptorT-LymphocyteTailTechniquesThrombosisTrainingTranscription Factor AP-1Transcriptional ActivationVisionWorkexperienceexperimental studyinsightmimeticsnovelnuclear factors of activated T-cellsparalogous genepathogenpharmacologicphosphoproteomicsprotein kinase C-deltareceptorresponseselective expressiontooltranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The overall vision of the proposed research is to gain a comprehensive understanding of how phosphorylation
regulates the activity and function of a key regulator of immune signaling, the Ser/Thr protein kinase C (PKC)
Theta (). This kinase is selectively expressed in hematopoietic cells where it transduces signals resulting in T
cell and platelet activation.1,2 Its dysregulation is associated with a variety of pathophysiological conditions
including blood cancers,3,4 inflammatory diseases,5 thrombosis,6 and hemostasis.7 Despite this, the regulation
and function of PKC remains largely unknown and necessitates further investigation. Phosphorylation of PKC
plays an essential role in regulating its maturation, catalytic activity, and subcellular localization,8 all of which are
crucial for PKC function in T cells and platelets. This proposal aims to understand how phosphorylation at
known conserved priming sites (activation loop, turn motif, hydrophobic motif),9 a bioinformatically-identified new
potential priming site (Ser662), and an uncharacterized activation-induced site (Ser685), regulate the maturation,
activity, and/or localization of PKC. Unbiased phosphoproteomics approaches have revealed that
phosphorylation of Ser685 significantly increases in T cells10 and platelets11 in response to stimulation, however
its function has not yet been determined due, in part, to a lack of available research tools. This site, and Ser662
are positioned on a key regulatory segment, the C-tail, and are evolutionarily conserved. The central hypothesis
driving this proposal is that phosphorylation of S662 is involved in the maturation of PKC and that activation-
induced phosphorylation of S685 promotes the re-autoinhibition of activated PKC to facilitate signal termination.
To this end, I will investigate how nonphosphorylatable or phosphomimetic mutations at these residues impact
PKC biochemical properties, cellular activity, subcellular localization, and downstream signaling (Aim 1).
Additionally, I will examine the phosphoproteome of PKC in Jurkat cells and platelets and examine how
phosphorylation at the agonist-induced site, Ser685, affects downstream signaling. I will also aim to identify the
kinase(s) regulating PKC Ser685 phosphorylation using various phosphoproteomics approaches (Aim 2).
These key studies will elucidate the functional impact of PKC phosphorylation at critical residues and how this
influences downstream signaling. Moreover, this proposal will elucidate substrates and signaling networks
regulated by PKC. Uncovering the regulation and function of PKC, a key regulator of T cells and platelets, is
crucial to understanding T cell and platelet signaling in both normal and disease states.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: